Nature, Published online: 12 November 2026; doi:10.1038/d41586-026-03684-x
Researchers are debating whether small, AI-enabled biotech companies are the future of drug discovery. Plus, even microplastics still reach the wildlife furthest from humanity and an upgrade to AlphaGenome.AI & ML
Daily briefing: Are one-person firms the future of biotech?
Nature News0 views
Source:https://www.nature.com/articles/d41586-026-03684-x
PreviousIs the sixth great extinction imminent? Scientists must draw on natural history for cluesNextThe secret to building Moon bases may be hiding in emergency blankets
Related posts

Nvidia amassed $530 billion in financial guarantees to corner the AI market — supply commitments rose by nearly a quarter of a trillion dollars in a single quarter
0Tom's Hardware

Senator slams Commerce Secretary for flow of Nvidia AI chips to China
0The Verge
They Found You Through a Photograph…
0dev.to
The Joy of Boring Code: Why Writing "Clever" Code is Overrated
0dev.to
From fMRI to images: what Brain-IT reconstructs—and what it does not
0dev.to
Vad ska vi automatisera först? En poängmodell för småföretag
0dev.to